Developer docs
API playgroundTry for free, no card

Search company profiles

Stiris Research

Full company profile

uuid000e2gb

Namestring
Stiris Research
Legal namestring
Stiris Research Inc.
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Stiris Research Inc. is a privately held, founder-owned contract research organization (CRO) founded in 2006 by Shantal Feltham, headquartered in London, Ontario with a US operational base in Cambridge, Massachusetts. The company provides full-service and focused clinical trial management for Phase I through Phase IIIB studies, primarily serving biotechnology and pharmaceutical sponsors with concentrations in rare diseases, neurology/CNS, and oncology. Its core offering is anchored by a proprietary web-based Clinical Trial Management System (CTMS) and validated Electronic Trial Master File (eTMF) that deliver real-time visibility into site status, enrollment, SAE tracking, and regulatory document management, supplemented by a 24/7 EDC help desk and proprietary data visualization tools for discrepancy management.

Stiris differentiates on a "site-first" operating model, with over 70% of its clinical team having prior site-level experience (75% former Clinical Research Coordinators, 60% Registered Nurses) and an explicit commitment to team stability through study lifecycles. Its services span project management, clinical monitoring, medical monitoring, regulatory affairs, biostatistics and data management, study start-up, auditing, and a dedicated Patient Caregiver Liaison (PCL) service for rare and CNS trials. A specialty in trial rescue — over 50 trials rescued and 20+ cited case studies — is a recurring narrative in its go-to-market.

Commercially, Stiris sells directly to biotech and pharmaceutical sponsors through relationship-driven enterprise sales, supplemented by conference presence (BIO, World Orphan Drug Congress, CNS Summit, ALS Drug Development Summit), case studies, and PR. Pricing is quote-based, project-based, and not publicly disclosed, with multi-year contracts ranging from full-service outsourcing to focused functional support. Global reach beyond North America is delivered through a strategic alliance partner network (notably in Asia-Pacific and Latin America) rather than owned offices. Revenue is not publicly disclosed; the firm has historically been recognized on Canadian growth lists (PROFIT 500, PROFIT W100) and is independent, with no disclosed institutional or private equity backing.

Short descriptiontext

Stiris Research is a privately held, founder-owned clinical research organization providing full-service and rescue-focused Phase I–IIIB clinical trial management for biotechnology and pharmaceutical sponsors, with specializations in rare diseases, neurology, and oncology across North America and select global markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, Canada
HQ citystring
London
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial management, contract research organization, clinical monitoring services, biostatistics data management, regulatory affairs services
Industry7 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Management Consulting Services54161
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Services8741
  • Services-Testing Laboratories8734
Product category
Contract Research Organization (CRO) / Clinical Trial Management Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Management Services
TypeProfessional Services
Description

Comprehensive CRO services including project management, clinical monitoring, medical monitoring, regulatory affairs, data management, biostatistics, study start-up, rescue services, and auditing. Revenue generated through project-based contracts for Phase I through Phase IIIB clinical trials.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom project-based pricing tailored to study requirements
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Services range from full-service outsourcing to focused clinical trial management.

GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Stiris Research is an entrepreneurial Clinical Trial Management CRO providing comprehensive study management solutions for Phase I through Phase IIIB clinical research for biotechnology and pharmaceutical companies. Services are tailor-made from full-service outsourcing to focused clinical trial management, including project management, clinical monitoring, medical monitoring, regulatory affairs, biostatistics and data management, rescue services, auditing, and study start-up. The offering is anchored by a proprietary web-based Clinical Trial Management System (CTMS) and validated Electronic Trial Master File (eTMF) platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 100% patient retention when using Patient Caregiver Liaison service; 100% of eligible patients transitioned to open-label extension study
+4 more records
Product overview1 text field

Stiris Research is an entrepreneurial Clinical Research Organization (CRO) providing comprehensive clinical trial management services for Phase I through Phase IIIB studies. The company's offering consists of a unified suite of clinical development services centered around their core Clinical Trial Management System (CTMS/eTMF) technology platform. Their service portfolio includes: Project Management, Clinical Monitoring (CRA services), Medical Monitoring, Rescue Services (for at-risk trials), Biostatistics and Data Management, Regulatory Affairs, Auditing, Study Start Up, and Global Coverage through strategic alliance partners. The company differentiates through a high-engagement model focused on site relationships and patient-centered trial execution, with particular expertise in rare diseases, neurology/neuromuscular disorders, and oncology. Their Patient Caregiver Liaison (PCL) Service provides dedicated support to reduce patient and caregiver burden and improve trial retention.

Product and service2 records
1Full-Service Clinical Trial Management
CategoryCore Service
2Project Management
CategoryCore Service
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Asia-Pacific CRO Alliance Partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Strategic alliance with an Asia-Pacific CRO for global study expansion, enabling Stiris to support trials in Australia-New Zealand region and other global markets beyond North America through seamless collaboration and single point of contact.

stirisresearch.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Top-5 global CRO with strong biotech and rare disease franchises. Overlaps Stiris's therapeutic focus but operates at materially larger scale across all phases and geographies.

TypeBroad incumbent
Description

Top-5 CRO with full-service Phase I-IV clinical and commercial services. Competes with Stiris on biotech Phase II-III programs, particularly where sponsors seek a single-vendor solution.

TypeBroad incumbent
Description

Top-5 global CRO with full-service Phase I-IV capabilities, including dedicated biotech and rare disease units. Competes with Stiris for biotech sponsors but at materially larger scale and broader service scope.

TypeDirect peer
Description

Mid-sized, biotech-focused CRO with full-service Phase I-IV capabilities and a reputation for operational excellence in complex indications. Closely comparable to Stiris in therapeutic specialization and biotech sponsor focus.

TypeDirect peer
Description

Mid-sized CRO specializing in oncology, rare disease, and CNS — comparable to Stiris in therapeutic focus and mid-sized biotech sponsor orientation.

TypeDirect peer
Description

Mid-sized CRO focused on biostatistics, data management, clinical programming, and regulatory submissions — closely comparable to Stiris's biostatistics/data management service line.

TypeDirect peer
Description

Mid-sized CRO focused on biotech and specialty pharma with strength in rare disease, neurology, oncology, and pediatrics — directly overlapping Stiris's core therapeutic areas and customer base.

TypeDirect peer
Description

Mid-sized global CRO providing full-service Phase I-IV clinical trial management with a strong footprint in biotech, rare disease, and CNS — directly comparable to Stiris's therapeutic focus and mid-sized positioning.

TypeBroad incumbent
Description

Largest global CRO with broad biotech offerings including dedicated rare disease and CNS teams. A direct competitor on enterprise bids where Stiris is too small to compete.

10Rho
TypeDirect peer
Description

Mid-sized CRO with strong biostatistics, data management, and regulatory capabilities supporting biotech and rare disease sponsors — comparable to Stiris on the technical/data services side of the offering.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Stiris Research

Contract Research Organization (CRO) / Clinical Trial Management Servicesstirisresearch.com

Stiris Research is a privately held, founder-owned clinical research organization providing full-service and rescue-focused Phase I–IIIB clinical trial management for biotechnology and pharmaceutical sponsors, with specializations in rare diseases, neurology, and oncology across North America and select global markets.

What Stiris Research does

Stiris Research Inc. is a privately held, founder-owned contract research organization (CRO) founded in 2006 by Shantal Feltham, headquartered in London, Ontario with a US operational base in Cambridge, Massachusetts. The company provides full-service and focused clinical trial management for Phase I through Phase IIIB studies, primarily serving biotechnology and pharmaceutical sponsors with concentrations in rare diseases, neurology/CNS, and oncology. Its core offering is anchored by a proprietary web-based Clinical Trial Management System (CTMS) and validated Electronic Trial Master File (eTMF) that deliver real-time visibility into site status, enrollment, SAE tracking, and regulatory document management, supplemented by a 24/7 EDC help desk and proprietary data visualization tools for discrepancy management.

Stiris differentiates on a "site-first" operating model, with over 70% of its clinical team having prior site-level experience (75% former Clinical Research Coordinators, 60% Registered Nurses) and an explicit commitment to team stability through study lifecycles. Its services span project management, clinical monitoring, medical monitoring, regulatory affairs, biostatistics and data management, study start-up, auditing, and a dedicated Patient Caregiver Liaison (PCL) service for rare and CNS trials. A specialty in trial rescue — over 50 trials rescued and 20+ cited case studies — is a recurring narrative in its go-to-market.

Commercially, Stiris sells directly to biotech and pharmaceutical sponsors through relationship-driven enterprise sales, supplemented by conference presence (BIO, World Orphan Drug Congress, CNS Summit, ALS Drug Development Summit), case studies, and PR. Pricing is quote-based, project-based, and not publicly disclosed, with multi-year contracts ranging from full-service outsourcing to focused functional support. Global reach beyond North America is delivered through a strategic alliance partner network (notably in Asia-Pacific and Latin America) rather than owned offices. Revenue is not publicly disclosed; the firm has historically been recognized on Canadian growth lists (PROFIT 500, PROFIT W100) and is independent, with no disclosed institutional or private equity backing.

Stiris Research firmographics

Firmographics
Name
Stiris Research
Legal name
Stiris Research Inc.
Website
https://stirisresearch.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Stiris Research is a privately held, founder-owned clinical research organization providing full-service and rescue-focused Phase I–IIIB clinical trial management for biotechnology and pharmaceutical sponsors, with specializations in rare diseases, neurology, and oncology across North America and select global markets.
Ownership category
akta.pro rank

Stiris Research industry classification

Industry
Product category
Contract Research Organization (CRO) / Clinical Trial Management Services
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Management Consulting Services (54161)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Management Services (8741), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination

Keywords

  • Clinical trial management
  • Contract research organization
  • Clinical monitoring services
  • Biostatistics data management
  • Regulatory affairs services

Where Stiris Research is headquartered

Location

Headquarters

HQ city
London
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Stiris Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial Management Services: Comprehensive CRO services including project management, clinical monitoring, medical monitoring, regulatory affairs, data management, biostatistics, study start-up, rescue services, and auditing. Revenue generated through project-based contracts for Phase I through Phase IIIB clinical trials.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing tailored to study requirements

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Stiris Research product offering

Product offering

Core offering

Stiris Research is an entrepreneurial Clinical Trial Management CRO providing comprehensive study management solutions for Phase I through Phase IIIB clinical research for biotechnology and pharmaceutical companies. Services are tailor-made from full-service outsourcing to focused clinical trial management, including project management, clinical monitoring, medical monitoring, regulatory affairs, biostatistics and data management, rescue services, auditing, and study start-up. The offering is anchored by a proprietary web-based Clinical Trial Management System (CTMS) and validated Electronic Trial Master File (eTMF) platform.

Product overview

Stiris Research is an entrepreneurial Clinical Research Organization (CRO) providing comprehensive clinical trial management services for Phase I through Phase IIIB studies. The company's offering consists of a unified suite of clinical development services centered around their core Clinical Trial Management System (CTMS/eTMF) technology platform. Their service portfolio includes: Project Management, Clinical Monitoring (CRA services), Medical Monitoring, Rescue Services (for at-risk trials), Biostatistics and Data Management, Regulatory Affairs, Auditing, Study Start Up, and Global Coverage through strategic alliance partners. The company differentiates through a high-engagement model focused on site relationships and patient-centered trial execution, with particular expertise in rare diseases, neurology/neuromuscular disorders, and oncology. Their Patient Caregiver Liaison (PCL) Service provides dedicated support to reduce patient and caregiver burden and improve trial retention.

Differentiator

Problem solved

Functional benefit

Products and services

  • Full-Service Clinical Trial Management
  • Project Management

Quantifiable outcome

  • 100% patient retention when using Patient Caregiver Liaison service; 100% of eligible patients transitioned to open-label extension study
  • +4 more outcomes

Companies that use Stiris Research

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Stiris Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Stiris Research partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Asia-Pacific CRO Alliance PartnercoreChannel Partner/ Reseller/ DistributorStrategic alliance with an Asia-Pacific CRO for global study expansion, enabling Stiris to support trials in Australia-New Zealand region and other global markets beyond North America through seamless collaboration and single point of contact.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Stiris Research competitors and assessment

Company assessment

Broad incumbents

  • Parexel: Top-5 global CRO with strong biotech and rare disease franchises. Overlaps Stiris's therapeutic focus but operates at materially larger scale across all phases and geographies.
  • Syneos Health: Top-5 CRO with full-service Phase I-IV clinical and commercial services. Competes with Stiris on biotech Phase II-III programs, particularly where sponsors seek a single-vendor solution.
  • ICON plc: Top-5 global CRO with full-service Phase I-IV capabilities, including dedicated biotech and rare disease units. Competes with Stiris for biotech sponsors but at materially larger scale and broader service scope.
  • IQVIA: Largest global CRO with broad biotech offerings including dedicated rare disease and CNS teams. A direct competitor on enterprise bids where Stiris is too small to compete.

Direct peers

  • Medpace: Mid-sized, biotech-focused CRO with full-service Phase I-IV capabilities and a reputation for operational excellence in complex indications. Closely comparable to Stiris in therapeutic specialization and biotech sponsor focus.
  • Biorasi: Mid-sized CRO specializing in oncology, rare disease, and CNS — comparable to Stiris in therapeutic focus and mid-sized biotech sponsor orientation.
  • MMS Holdings: Mid-sized CRO focused on biostatistics, data management, clinical programming, and regulatory submissions — closely comparable to Stiris's biostatistics/data management service line.
  • Premier Research: Mid-sized CRO focused on biotech and specialty pharma with strength in rare disease, neurology, oncology, and pediatrics — directly overlapping Stiris's core therapeutic areas and customer base.
  • Worldwide Clinical Trials: Mid-sized global CRO providing full-service Phase I-IV clinical trial management with a strong footprint in biotech, rare disease, and CNS — directly comparable to Stiris's therapeutic focus and mid-sized positioning.
  • Rho: Mid-sized CRO with strong biostatistics, data management, and regulatory capabilities supporting biotech and rare disease sponsors — comparable to Stiris on the technical/data services side of the offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Stiris Research social profiles

Digital presence

Stiris Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Stiris Research leadership team

Management profile

Number of profiles

Profiles7 records

Stiris Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Stiris Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stiris Research

What does Stiris Research do?

Stiris Research is an entrepreneurial Clinical Trial Management CRO providing comprehensive study management solutions for Phase I through Phase IIIB clinical research for biotechnology and pharmaceutical companies. Services are tailor-made from full-service outsourcing to focused clinical trial management, including project management, clinical monitoring, medical monitoring, regulatory affairs, biostatistics and data management, rescue services, auditing, and study start-up. The offering is anchored by a proprietary web-based Clinical Trial Management System (CTMS) and validated Electronic Trial Master File (eTMF) platform.

Is Stiris Research a public or private company?

Stiris Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Stiris Research founded?

Stiris Research was founded in 2006. It employs 11 to 50 people.

Where is Stiris Research based?

Stiris Research is headquartered in London, Canada, in the North America region.

How does Stiris Research make money?

One revenue line is on record: clinical Trial Management Services.

Who are Stiris Research's main competitors?

Broad incumbents on record are Parexel, Syneos Health, ICON plc and IQVIA. Direct peers are Medpace, Biorasi, MMS Holdings, Premier Research, Worldwide Clinical Trials and Rho.

Does Stiris Research have an API?

No public API is recorded for Stiris Research.

What industry is Stiris Research in?

Stiris Research's product category is Contract Research Organization (CRO) / Clinical Trial Management Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales